Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis

Defining Left Ventricular Hypertrophy in Children on Peritoneal Dialysis

(2011) D. Borzych et al.   Clinical Journal of the American Society of Nephrology

Cardiac Geometry in Children Receiving Chronic Peritoneal Dialysis: Findings from the International Pediatric Peritoneal Dialysis Network (IPPN) Registry

(2011) S. A. Bakkaloglu et al.   Clinical Journal of the American Society of Nephrology

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Cardiovascular complications in children with chronic kidney disease

(2011) Rukshana Shroff et al.   Nature Reviews Nephrology

Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients

(2011) Poyyapakkam R. Srivaths et al.   PEDIATRIC NEPHROLOGY

Vitamin D deficiency and heart disease

(2011) Stefan Pilz et al.   Kidney International Supplements

N-terminal proBNP--Marker of Cardiac Dysfunction, Fluid Overload, or Malnutrition in Hemodialysis Patients?

(2010) J. Booth et al.   Clinical Journal of the American Society of Nephrology

Myocardial effects of VDR activators in renal failure

(2010) Masahide Mizobuchi et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease

(2010) Michael van Husen et al.   KIDNEY INTERNATIONAL

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

(2010) Hisashi Hasegawa et al.   KIDNEY INTERNATIONAL

Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

(2010) A. Kirkpantur et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients

(2009) Heng Jung Hsu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

(2009) Takashi Shimada et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Vitamin D Insufficiency and Deficiency in Children with Early Chronic Kidney Disease

(2009) Wacharee Seeherunvong et al.   JOURNAL OF PEDIATRICS

Age-Specific Reference Intervals for Indexed Left Ventricular Mass in Children

(2009) Philip R. Khoury et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis

(2009) M. Shawkat Razzaque   Nature Reviews Endocrinology

Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis

(2008) Katherine Wesseling-Perry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Suppression of renin–angiotensin gene expression in the kidney by paricalcitol

(2008) Michael Freundlich et al.   KIDNEY INTERNATIONAL

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE

THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Cardiovascular Disease in Chronic Renal Failure: Pathophysiologic Aspects

(2004) Gérard M. London   SEMINARS IN DIALYSIS